(Q45176483)

10 December 2017

title

Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study (English)

1 reference

10 December 2017

1 reference

1 reference

1 reference

8

Göran Hallmans

1 reference

10 December 2017

11

Christel Häggström

1 reference

10 December 2017

6

Tone Bjørge

1 reference

10 December 2017

12

Anders Engeland

1 reference

10 December 2017

13

Steinar Tretli

1 reference

10 December 2017

2

Tanja Stocks

1 reference

10 December 2017

7

Jonas Manjer

1 reference

10 December 2017

17

Hanno Ulmer

1 reference

10 December 2017

14

Hans Concin

1 reference

10 December 2017

9

Randi Selmer

1 reference

10 December 2017

5

Gabriele Nagel

1 reference

10 December 2017

3

Håkan Jonsson

1 reference

10 December 2017

16

Pär Stattin

1 reference

10 December 2017

1

Wegene Borena

1 reference

10 December 2017

4

Susanne Strohmaier

1 reference

10 December 2017

10

Martin Almquist

1 reference

10 December 2017

Alexander Strasak

15

1 reference

10 December 2017

publication date

8 December 2010

1 reference

10 December 2017

published in

Cancer Causes & Control

1 reference

10 December 2017

volume

22

1 reference

10 December 2017

issue

2

1 reference

10 December 2017

page(s)

291-299

1 reference

Triglycerides and the Risk of Coronary Heart Disease

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

Fasting versus nonfasting triglycerides and the prediction of cardiovascular risk: do we need to revisit the oral triglyceride tolerance test?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

Serum triglycerides and risk of coronary heart disease among Japanese men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

The metabolic syndrome: A high-risk state for cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

Serum triglyceride concentrations and cancer risk in a large cohort study in Austria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

Prospective study of the association of serum triglyceride and glucose with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

Breast cancer incidence in ex-smokers in relation to body mass index, weight gain and blood lipid levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

The metabolic syndrome is associated with reduced risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

Long-term temporal trends in cardiovascular and metabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

Underestimation of Risk Associations Due to Regression Dilution in Long-term Follow-up of Prospective Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

Estrogen replacement therapy and colon cancer: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

Clinical practice. Hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

Redox regulation of cellular signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

Fasting versus nonfasting triglycerides: implications for laboratory measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

Hypertriglyceridemia: its etiology, effects and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-010-9697-0

10.1007/S10552-010-9697-0

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

10 December 2017

1048128577

0 references

1 reference